| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.99e-06 | 127 | 92 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.48e-05 | 37 | 92 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.84e-05 | 262 | 92 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 1.25e-04 | 4 | 92 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | myosin light chain kinase activity | 1.25e-04 | 4 | 92 | 2 | GO:0004687 | |
| GeneOntologyMolecularFunction | histone binding | 2.25e-04 | 265 | 92 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.26e-04 | 614 | 92 | 10 | GO:0140657 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 5.77e-04 | 8 | 92 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | chromatin binding | SUPT6H SMARCA2 CHD4 TAF1 SSRP1 FANCM NCAPH TOP2A TOP2B PRIMPOL BAHCC1 | 5.82e-04 | 739 | 92 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 6.05e-04 | 36 | 92 | 3 | GO:0070273 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 6.46e-04 | 316 | 92 | 7 | GO:0035091 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 6.99e-04 | 231 | 92 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | small GTPase binding | 7.08e-04 | 321 | 92 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | VPS72 RSF1 XRN1 SMARCA2 CHD4 FANCM TOP2A TOP2B PRIMPOL DDX10 | 7.68e-04 | 645 | 92 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | retromer complex binding | 9.22e-04 | 10 | 92 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | phosphatidylinositol transfer activity | 1.12e-03 | 11 | 92 | 2 | GO:0008526 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.38e-03 | 360 | 92 | 7 | GO:0051020 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 1.41e-03 | 48 | 92 | 3 | GO:0032266 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.50e-03 | 49 | 92 | 3 | GO:0005547 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 2.28e-03 | 199 | 92 | 5 | GO:1901981 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 2.31e-03 | 57 | 92 | 3 | GO:0120013 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.51e-03 | 66 | 92 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.51e-03 | 66 | 92 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 3.78e-03 | 20 | 92 | 2 | GO:0003746 | |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1.88e-05 | 2 | 90 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | resolution of meiotic recombination intermediates | 6.25e-05 | 18 | 90 | 3 | GO:0000712 | |
| GeneOntologyBiologicalProcess | maturation of SSU-rRNA | 9.75e-05 | 55 | 90 | 4 | GO:0030490 | |
| GeneOntologyBiologicalProcess | ribosomal small subunit biogenesis | 1.11e-04 | 108 | 90 | 5 | GO:0042274 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 1.11e-04 | 336 | 90 | 8 | GO:0042254 | |
| GeneOntologyBiologicalProcess | female meiosis chromosome separation | 1.12e-04 | 4 | 90 | 2 | GO:0051309 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 2.02e-04 | 275 | 90 | 7 | GO:0016072 | |
| GeneOntologyBiologicalProcess | DNA recombination | 2.07e-04 | 368 | 90 | 8 | GO:0006310 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 2.18e-04 | 371 | 90 | 8 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 2.18e-04 | 371 | 90 | 8 | GO:0104004 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 1.09e-04 | 4 | 90 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | preribosome | 1.34e-04 | 114 | 90 | 5 | GO:0030684 | |
| GeneOntologyCellularComponent | 90S preribosome | 2.60e-04 | 29 | 90 | 3 | GO:0030686 | |
| Domain | DNA_topoisoIV | 2.35e-05 | 2 | 91 | 2 | PF00521 | |
| Domain | EF1_GNE | 2.35e-05 | 2 | 91 | 2 | PF00736 | |
| Domain | Transl_elong_EF1B_B/D_CS | 2.35e-05 | 2 | 91 | 2 | IPR001326 | |
| Domain | Topo_IIA_A/C_ab | 2.35e-05 | 2 | 91 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 2.35e-05 | 2 | 91 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 2.35e-05 | 2 | 91 | 2 | IPR013759 | |
| Domain | - | 2.35e-05 | 2 | 91 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 2.35e-05 | 2 | 91 | 2 | IPR012542 | |
| Domain | TOP4c | 2.35e-05 | 2 | 91 | 2 | SM00434 | |
| Domain | TOP2c | 2.35e-05 | 2 | 91 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 2.35e-05 | 2 | 91 | 2 | IPR013760 | |
| Domain | EF1_GNE | 2.35e-05 | 2 | 91 | 2 | SM00888 | |
| Domain | Topo_IIA_bsu_dom2 | 2.35e-05 | 2 | 91 | 2 | IPR013506 | |
| Domain | DTHCT | 2.35e-05 | 2 | 91 | 2 | PF08070 | |
| Domain | EF1BD_1 | 2.35e-05 | 2 | 91 | 2 | PS00824 | |
| Domain | EF1BD_2 | 2.35e-05 | 2 | 91 | 2 | PS00825 | |
| Domain | DNA_gyraseB | 2.35e-05 | 2 | 91 | 2 | PF00204 | |
| Domain | - | 2.35e-05 | 2 | 91 | 2 | 1.10.268.10 | |
| Domain | EF-1_beta_acid | 2.35e-05 | 2 | 91 | 2 | PF10587 | |
| Domain | TOPRIM_C | 2.35e-05 | 2 | 91 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 2.35e-05 | 2 | 91 | 2 | PF16898 | |
| Domain | - | 2.35e-05 | 2 | 91 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 2.35e-05 | 2 | 91 | 2 | IPR018522 | |
| Domain | EF-1_beta_acid | 2.35e-05 | 2 | 91 | 2 | SM01182 | |
| Domain | EF1B_bsu/dsu_GNE | 2.35e-05 | 2 | 91 | 2 | IPR014038 | |
| Domain | EF-1_beta_acid_region_euk | 2.35e-05 | 2 | 91 | 2 | IPR018940 | |
| Domain | FAM21 | 2.35e-05 | 2 | 91 | 2 | IPR027308 | |
| Domain | Topo_IIA_A/C | 2.35e-05 | 2 | 91 | 2 | IPR002205 | |
| Domain | Topo_IIA | 2.35e-05 | 2 | 91 | 2 | IPR001241 | |
| Domain | TOPOISOMERASE_II | 2.35e-05 | 2 | 91 | 2 | PS00177 | |
| Domain | - | 7.02e-05 | 3 | 91 | 2 | 3.30.1360.40 | |
| Domain | Transl_elong_EF1B/ribosomal_S6 | 7.02e-05 | 3 | 91 | 2 | IPR014717 | |
| Domain | - | 7.02e-05 | 3 | 91 | 2 | 3.30.70.60 | |
| Domain | Arg_repress_C-like | 7.02e-05 | 3 | 91 | 2 | IPR024946 | |
| Domain | FAM21/CAPZIP | 7.02e-05 | 3 | 91 | 2 | IPR029341 | |
| Domain | CAP-ZIP_m | 7.02e-05 | 3 | 91 | 2 | PF15255 | |
| Domain | Toprim_domain | 1.40e-04 | 4 | 91 | 2 | IPR006171 | |
| Domain | Toprim | 1.40e-04 | 4 | 91 | 2 | PF01751 | |
| Domain | TOPRIM | 1.40e-04 | 4 | 91 | 2 | PS50880 | |
| Domain | - | 2.68e-04 | 64 | 91 | 4 | 3.40.50.1000 | |
| Domain | DUF3398 | 3.48e-04 | 6 | 91 | 2 | PF11878 | |
| Domain | LNS2 | 3.48e-04 | 6 | 91 | 2 | PF08235 | |
| Domain | LNS2 | 3.48e-04 | 6 | 91 | 2 | IPR013209 | |
| Domain | PI_transfer | 3.48e-04 | 6 | 91 | 2 | IPR001666 | |
| Domain | LNS2 | 3.48e-04 | 6 | 91 | 2 | SM00775 | |
| Domain | DDHD | 3.48e-04 | 6 | 91 | 2 | PF02862 | |
| Domain | DDHD | 3.48e-04 | 6 | 91 | 2 | PS51043 | |
| Domain | LNS2/PITP | 3.48e-04 | 6 | 91 | 2 | IPR031315 | |
| Domain | DDHD_dom | 3.48e-04 | 6 | 91 | 2 | IPR004177 | |
| Domain | DOCK_C/D_N | 3.48e-04 | 6 | 91 | 2 | IPR021816 | |
| Domain | DDHD | 3.48e-04 | 6 | 91 | 2 | SM01127 | |
| Domain | HAD-like_dom | 5.99e-04 | 79 | 91 | 4 | IPR023214 | |
| Domain | RuvA_2-like | 8.27e-04 | 9 | 91 | 2 | IPR010994 | |
| Domain | DOCK_C | 1.25e-03 | 11 | 91 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.25e-03 | 11 | 91 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.25e-03 | 11 | 91 | 2 | PS51651 | |
| Domain | DHR_1 | 1.25e-03 | 11 | 91 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.25e-03 | 11 | 91 | 2 | PF14429 | |
| Domain | DHR-2 | 1.25e-03 | 11 | 91 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.25e-03 | 11 | 91 | 2 | PF06920 | |
| Domain | DOCK | 1.25e-03 | 11 | 91 | 2 | IPR026791 | |
| Domain | Helicase_C | 1.86e-03 | 107 | 91 | 4 | PF00271 | |
| Domain | HELICc | 1.86e-03 | 107 | 91 | 4 | SM00490 | |
| Domain | Helicase_C | 1.92e-03 | 108 | 91 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.99e-03 | 109 | 91 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.99e-03 | 109 | 91 | 4 | PS51192 | |
| Domain | DEXDc | 1.99e-03 | 109 | 91 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.05e-03 | 110 | 91 | 4 | IPR014001 | |
| Domain | - | 2.99e-03 | 391 | 91 | 7 | 2.30.29.30 | |
| Domain | HATPase_c | 3.41e-03 | 18 | 91 | 2 | SM00387 | |
| Domain | HATPase_c | 3.80e-03 | 19 | 91 | 2 | PF02518 | |
| Domain | - | 4.21e-03 | 20 | 91 | 2 | 3.30.565.10 | |
| Domain | - | 4.64e-03 | 21 | 91 | 2 | 3.30.230.10 | |
| Domain | HATPase_C | 4.64e-03 | 21 | 91 | 2 | IPR003594 | |
| Domain | PH_dom-like | 4.78e-03 | 426 | 91 | 7 | IPR011993 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 2.07e-04 | 5 | 65 | 2 | MM14587 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION | 2.07e-04 | 5 | 65 | 2 | MM14603 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 2.07e-04 | 5 | 65 | 2 | M26962 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 5.25e-04 | 81 | 65 | 4 | M865 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 5.51e-04 | 35 | 65 | 3 | M16801 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 5.76e-04 | 83 | 65 | 4 | MM15314 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 8.84e-04 | 93 | 65 | 4 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 9.20e-04 | 94 | 65 | 4 | M41818 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 9.20e-04 | 10 | 65 | 2 | M7239 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 1.12e-03 | 11 | 65 | 2 | MM1349 | |
| Pathway | SIG_CHEMOTAXIS | 1.16e-03 | 45 | 65 | 3 | M5193 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.26e-03 | 175 | 65 | 5 | MM15599 | |
| Pubmed | DMXL2 FRAS1 RAB3GAP1 SLC4A1AP CEBPZ CCDC47 SUPT6H CTR9 CWC15 ECD BMS1 CCSER2 VPS13A RCN2 KRI1 AKAP11 LTV1 CTNNA1 HNRNPUL1 SSRP1 IPO4 SEC63 WASHC2A ERBIN PBXIP1 SNX2 TOP2B PPM1G DDX10 CDC42EP1 | 7.34e-19 | 1487 | 92 | 30 | 33957083 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | EEF1B2 OSBP EEF1D SLC4A1AP SUPT6H RSF1 BMS1 LTV1 CHD4 MPHOSPH10 SSRP1 TOP2A | 1.96e-14 | 163 | 92 | 12 | 22113938 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EEF1B2 EEF1D RBM25 ZBTB33 VPS72 SLC4A1AP CEBPZ CWC15 RSF1 ZNF638 KRI1 NOL7 CHD4 MPHOSPH10 TAF1 HNRNPUL1 SSRP1 FANCM TOP2A TOP2B DDX10 | 5.84e-14 | 954 | 92 | 21 | 36373674 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | EEF1D RBM25 SLC4A1AP CEBPZ SUPT6H CTR9 BMS1 ZNF638 KRI1 NOL7 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 IPO4 SEC63 ERBIN TOP2A TOP2B PPM1G DDX10 | 1.17e-13 | 989 | 92 | 21 | 36424410 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | ZBTB33 CEBPZ ZNF638 KRI1 CHD4 MPHOSPH10 HNRNPUL1 TOP2A TOP2B PPM1G DDX10 | 2.27e-13 | 148 | 92 | 11 | 32538781 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EEF1B2 EEF1D RBM25 CEBPZ CCDC47 SUPT6H CTR9 RGS22 BMS1 RCN2 KRI1 NOL7 APLP2 LTV1 CHD4 HNRNPUL1 SSRP1 IPO4 SEC63 NCAPH TOP2A SNX2 TOP2B DDX10 | 2.30e-13 | 1425 | 92 | 24 | 30948266 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EEF1B2 EEF1D RBM25 CEBPZ CCDC47 CTR9 CWC15 BMS1 SMARCA2 KRI1 NOL7 LTV1 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 IPO4 SEC63 NCAPH TOP2A SNX2 TOP2B DDX10 | 3.87e-13 | 1318 | 92 | 23 | 30463901 |
| Pubmed | RBM25 CEBPZ SUPT6H RSF1 BMS1 XRN1 SMARCA2 ZNF638 KRI1 CUL9 CHD4 MPHOSPH10 CTNNA1 HNRNPUL1 IPO4 PPM1G DDX10 | 1.39e-12 | 653 | 92 | 17 | 22586326 | |
| Pubmed | SUPT6H CTR9 CWC15 KRI1 APLP2 EGFLAM LTV1 MPHOSPH10 SSRP1 TOP2A TOP2B PPM1G | 3.34e-12 | 251 | 92 | 12 | 28077445 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EEF1B2 EEF1D RAB3GAP1 CEBPZ CCDC47 CTR9 RSF1 BMS1 XRN1 SMARCA2 DOCK10 ZNF638 LTV1 CHD4 HNRNPUL1 SSRP1 IPO4 NCAPH ERBIN TOP2A TOP2B DDX10 | 5.51e-12 | 1353 | 92 | 22 | 29467282 |
| Pubmed | EEF1B2 OSBP EEF1D FRAS1 RBM25 VPS72 SUPT6H CTR9 CFDP1 RSF1 RCN2 KRI1 SSRP1 IPO4 SEC63 PPM1G | 1.67e-11 | 653 | 92 | 16 | 33742100 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EEF1B2 OSBP RBM25 PDE4C WASHC2C SLC4A1AP CTR9 SMARCA2 ZNF638 CHD4 CTNNA1 HNRNPUL1 SSRP1 ERBIN TOP2A SNX2 TOP2B | 2.02e-11 | 774 | 92 | 17 | 15302935 |
| Pubmed | EEF1B2 STRN VPS72 SLC4A1AP CEBPZ CCDC47 SUPT6H CTR9 BMS1 XRN1 SMARCA2 RCN2 NOL7 APLP2 MPHOSPH10 SSRP1 IPO4 SEC63 ERBIN PBXIP1 MYLK2 DDX10 | 3.89e-11 | 1497 | 92 | 22 | 31527615 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EEF1B2 EEF1D RBM25 CEBPZ CWC15 ECD BMS1 RCN2 ZNF638 KRI1 LTV1 MPHOSPH10 CTNNA1 HNRNPUL1 SSRP1 IPO4 SEC63 NCAPH TOP2A PPM1G | 8.76e-11 | 1257 | 92 | 20 | 36526897 |
| Pubmed | EEF1B2 EEF1D RAB3GAP1 CEBPZ CCDC47 ECD BMS1 RCN2 KRI1 CHD4 CTNNA1 HNRNPUL1 SSRP1 IPO4 SEC63 NCAPH ERBIN PBXIP1 TOP2A TOP2B PPM1G | 1.35e-10 | 1440 | 92 | 21 | 30833792 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | EEF1B2 EEF1D RBM25 ZBTB33 CEBPZ ZNF638 CHD4 SSRP1 TOP2A TOP2B DDX10 | 1.62e-10 | 271 | 92 | 11 | 32433965 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ZBTB33 CFDP1 BMS1 ZNF638 KRI1 TAF1 SSRP1 TOP2A TOP2B PPM1G DDX10 | 2.56e-10 | 283 | 92 | 11 | 30585729 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EEF1B2 ZBTB33 WASHC2C CWC15 ECD CFDP1 RSF1 XRN1 ZNF638 LTV1 CHD4 HNRNPUL1 NCAPH ERBIN TOP2A TOP2B DDX10 | 3.64e-10 | 934 | 92 | 17 | 33916271 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EEF1B2 EEF1D SLC4A1AP CEBPZ CCDC47 SUPT6H CTR9 ECD PBK ZNF638 KRI1 LTV1 CHD4 CTNNA1 HNRNPUL1 SSRP1 NCAPH TOP2A TOP2B PPM1G | 6.90e-10 | 1415 | 92 | 20 | 28515276 |
| Pubmed | RBM25 MYLK CEBPZ CWC15 BMS1 MPHOSPH10 CTNNA1 SSRP1 TOP2A PPM1G DDX10 CDC42EP1 | 7.84e-10 | 403 | 92 | 12 | 35253629 | |
| Pubmed | EEF1B2 EEF1D STRN MYLK CEBPZ CCDC47 CTR9 ECD RSF1 VPS13A XRN1 CHD4 MPHOSPH10 SSRP1 NCAPH ERBIN TOP2A TOP2B MYLK2 BAHCC1 | 9.55e-10 | 1442 | 92 | 20 | 35575683 | |
| Pubmed | OSBP EEF1D RAB3GAP1 VIPAS39 VPS72 CCDC47 CWC15 PBK APLP2 LTV1 HNRNPUL1 SSRP1 ERBIN PBXIP1 SNX2 YIPF3 CDC42EP1 | 1.13e-09 | 1007 | 92 | 17 | 34597346 | |
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 1.21e-09 | 41 | 92 | 6 | 15561718 | |
| Pubmed | RBM25 CEBPZ BMS1 XRN1 ZNF638 KRI1 MPHOSPH10 SSRP1 TOP2A TOP2B DDX10 | 1.37e-09 | 332 | 92 | 11 | 25693804 | |
| Pubmed | SLC4A1AP SUPT6H CTR9 RSF1 ZNF638 CHD4 HNRNPUL1 SSRP1 TOP2A TOP2B | 1.38e-09 | 251 | 92 | 10 | 31076518 | |
| Pubmed | 1.60e-09 | 125 | 92 | 8 | 29467281 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | VPS72 CEBPZ SUPT6H CTR9 CCSER2 SMARCA2 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 TOP2A TOP2B | 2.11e-09 | 440 | 92 | 12 | 34244565 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | EEF1B2 ZBTB33 CEBPZ RSF1 BMS1 RCN2 KRI1 CHD4 MPHOSPH10 PPM1G DDX10 | 2.31e-09 | 349 | 92 | 11 | 25665578 |
| Pubmed | EEF1D RBM25 ZBTB33 VPS72 CFDP1 BMS1 XRN1 SMARCA2 RCN2 ZNF638 KRI1 CUL9 LTV1 TAF1 HNRNPUL1 WASHC2A ERBIN PPM1G DDX10 | 5.34e-09 | 1429 | 92 | 19 | 35140242 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RBM25 CEBPZ SUPT6H CTR9 BMS1 SMARCA2 ZNF638 KRI1 CHD4 SSRP1 TOP2A TOP2B DDX10 | 7.47e-09 | 605 | 92 | 13 | 28977666 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | RBM25 CTR9 CHD4 CTNNA1 HNRNPUL1 SSRP1 IPO4 TOP2A SNX2 TOP2B PPM1G | 9.49e-09 | 400 | 92 | 11 | 35013556 |
| Pubmed | VIPAS39 SLC4A1AP CEBPZ CCDC47 CTR9 BMS1 VPS13A RCN2 ZNF638 KRI1 APLP2 CTNNA1 WASF1 ERBIN PPM1G CDC42EP1 | 1.54e-08 | 1049 | 92 | 16 | 27880917 | |
| Pubmed | VIPAS39 ZBTB33 BMS1 VPS13A XRN1 ZNF638 CHD4 HNRNPUL1 IPO4 NCAPH WASF1 ERBIN PPM1G CDC42EP1 | 1.73e-08 | 777 | 92 | 14 | 35844135 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.87e-08 | 330 | 92 | 10 | 33301849 | |
| Pubmed | CEBPZ SUPT6H CWC15 RSF1 ZNF638 CTNNA1 SSRP1 NCAPH HYDIN TOP2A TOP2B | 4.81e-08 | 469 | 92 | 11 | 27634302 | |
| Pubmed | PITPNM2 EEF1B2 OSBP EEF1D DMXL2 STRN RAB3GAP1 VIPAS39 WASHC2C DOCK9 XRN1 PITPNM3 WASHC2A WASF1 ERBIN PPM1G | 4.81e-08 | 1139 | 92 | 16 | 36417873 | |
| Pubmed | 6.14e-08 | 131 | 92 | 7 | 31006538 | ||
| Pubmed | EEF1B2 EEF1D RBM25 SUPT6H CTR9 CFDP1 RSF1 SMARCA2 CHD4 TAF1 SSRP1 NCAPH TOP2A TOP2B PPM1G | 6.81e-08 | 1014 | 92 | 15 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EEF1B2 EEF1D RBM25 CEBPZ SUPT6H ZNF638 NOL7 CHD4 CTNNA1 HNRNPUL1 SSRP1 TOP2A SNX2 TOP2B DDX10 | 7.73e-08 | 1024 | 92 | 15 | 24711643 |
| Pubmed | 8.66e-08 | 208 | 92 | 8 | 11790298 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EEF1B2 EEF1D ZBTB33 CCDC47 CWC15 CFDP1 BMS1 SMARCA2 CHD4 CTNNA1 HNRNPUL1 SSRP1 IPO4 NCAPH ERBIN TOP2A PPM1G | 1.00e-07 | 1367 | 92 | 17 | 32687490 |
| Pubmed | 1.03e-07 | 43 | 92 | 5 | 26030138 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CEBPZ BMS1 XRN1 KRI1 NOL7 LTV1 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 TOP2A TOP2B DDX10 | 1.05e-07 | 759 | 92 | 13 | 35915203 |
| Pubmed | 1.15e-07 | 86 | 92 | 6 | 37253089 | ||
| Pubmed | FRAS1 RIPOR2 WASHC2C MYO10 DOCK9 PEG3 DOCK10 CUL9 WASHC2A ERBIN | 1.33e-07 | 407 | 92 | 10 | 12693553 | |
| Pubmed | RBM25 ZBTB33 VPS72 CEBPZ XRN1 TAF1 SSRP1 NCAPH ERBIN TOP2A SNX2 | 2.33e-07 | 549 | 92 | 11 | 38280479 | |
| Pubmed | RBM25 ZBTB33 VPS72 RSF1 ZNF316 XRN1 SMARCA2 RCN2 CUL9 CHD4 TAF1 SSRP1 TOP2A BAHCC1 CDC42EP1 | 2.33e-07 | 1116 | 92 | 15 | 31753913 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 3.32e-07 | 248 | 92 | 8 | 27926873 | |
| Pubmed | 3.38e-07 | 103 | 92 | 6 | 32744500 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EEF1B2 EEF1D RAB3GAP1 CEBPZ CCDC47 SMARCA2 CHD4 SSRP1 IPO4 NCAPH TOP2A TOP2B | 3.57e-07 | 704 | 92 | 12 | 29955894 |
| Pubmed | EEF1B2 EEF1D RBM25 WASHC2C CEBPZ BMS1 ZNF638 KRI1 CHD4 MPHOSPH10 SSRP1 TOP2A TOP2B | 3.67e-07 | 847 | 92 | 13 | 35850772 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EEF1B2 EEF1D RBM25 SLC4A1AP SUPT6H ECD PBK SMARCA2 LTV1 CHD4 SSRP1 NCAPH PPM1G | 3.67e-07 | 847 | 92 | 13 | 35235311 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EEF1D ZBTB33 CFDP1 BMS1 CUL9 CHD4 SPIDR NCAPH WASF1 TOP2A SNX2 TOP2B ANKRD26P1 | 4.19e-07 | 857 | 92 | 13 | 25609649 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 4.61e-07 | 259 | 92 | 8 | 30404004 | |
| Pubmed | RBM25 CEBPZ CTR9 CWC15 BMS1 KRI1 NOL7 CHD4 HNRNPUL1 SSRP1 TOP2A DDX10 | 5.31e-07 | 731 | 92 | 12 | 29298432 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 5.35e-07 | 180 | 92 | 7 | 30110629 | |
| Pubmed | VIPAS39 ZBTB33 CEBPZ CCDC47 CWC15 XRN1 RCN2 ZNF638 SEC63 WASHC2A ERBIN YIPF3 | 5.47e-07 | 733 | 92 | 12 | 34672954 | |
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 5.76e-07 | 182 | 92 | 7 | 26527279 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PITPNM2 HROB MYO10 CTR9 ECD XRN1 LTV1 SNX21 TYSND1 SSRP1 WASHC2A ERBIN ZNHIT3 CDC42EP1 | 5.91e-07 | 1038 | 92 | 14 | 26673895 |
| Pubmed | CEBPZ BMS1 ZNF638 KRI1 NOL7 CHD4 MPHOSPH10 SSRP1 TOP2A DDX10 | 6.35e-07 | 483 | 92 | 10 | 36912080 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SLC4A1AP CFDP1 RSF1 NOL7 CHD4 TAF1 SSRP1 TOP2A TOP2B PPM1G DDX10 | 6.37e-07 | 608 | 92 | 11 | 36089195 |
| Pubmed | DMXL2 VIPAS39 WASHC2C CCDC47 VPS13A AKAP11 SEC63 WASHC2A SNX2 YIPF3 | 9.32e-07 | 504 | 92 | 10 | 34432599 | |
| Pubmed | OSBP RAB3GAP1 CCDC47 RSF1 VPS13A SMARCA2 PITPNM3 NOL7 LTV1 MPHOSPH10 WASF1 | 1.02e-06 | 638 | 92 | 11 | 31182584 | |
| Pubmed | 1.12e-06 | 201 | 92 | 7 | 34917906 | ||
| Pubmed | EEF1B2 EEF1D CWC15 RCN2 CHD4 CTNNA1 HNRNPUL1 SSRP1 TOP2A SNX2 TOP2B PPM1G | 1.13e-06 | 786 | 92 | 12 | 29128334 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.54e-06 | 533 | 92 | 10 | 30554943 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | EEF1B2 CTR9 ECD BMS1 XRN1 RCN2 KRI1 APLP2 CTNNA1 IPO4 SEC63 SNX2 PPM1G | 1.74e-06 | 974 | 92 | 13 | 28675297 |
| Pubmed | 1.76e-06 | 419 | 92 | 9 | 15635413 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | STRN WASHC2C CWC15 ECD CCSER2 SMARCA2 RCN2 LTV1 CTNNA1 HNRNPUL1 WASHC2A ZNHIT3 TOP2A TOP2B | 2.07e-06 | 1155 | 92 | 14 | 20360068 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | STRN COPS9 ZBTB33 MYO10 SUPT6H BMS1 SMARCA2 KRI1 CHD4 TYSND1 IPO4 PPM1G DDX10 | 2.46e-06 | 1005 | 92 | 13 | 19615732 |
| Pubmed | PITPNM2 OSBP RAB3GAP1 VIPAS39 WASHC2C CCDC47 PBK PITPNM3 CUL9 NOL7 WASHC2A NCAPH ERBIN | 2.48e-06 | 1006 | 92 | 13 | 15226823 | |
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 2.53e-06 | 36 | 92 | 4 | 29089422 | |
| Pubmed | RBM25 ZBTB33 CCDC47 XRN1 RCN2 LTV1 CTNNA1 SEC63 ERBIN PPM1G CDC42EP1 | 2.78e-06 | 708 | 92 | 11 | 39231216 | |
| Pubmed | EEF1D RBM25 CEBPZ CCDC47 CWC15 PEG3 BMS1 RCN2 KRI1 NOL7 LTV1 CHD4 SSRP1 SEC63 DDX10 | 3.03e-06 | 1371 | 92 | 15 | 36244648 | |
| Pubmed | 3.08e-06 | 234 | 92 | 7 | 36243803 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | STRN WASHC2C VPS72 SUPT6H CTR9 CUL9 IPO4 CFAP44 WASHC2A PPM1G | 3.68e-06 | 588 | 92 | 10 | 38580884 |
| Pubmed | 3.84e-06 | 242 | 92 | 7 | 34011540 | ||
| Pubmed | EEF1B2 EEF1D CCDC47 RCN2 LTV1 CHD4 HNRNPUL1 SSRP1 TOP2A TOP2B | 4.46e-06 | 601 | 92 | 10 | 33658012 | |
| Pubmed | EEF1B2 STRN SLC4A1AP CWC15 BMS1 SMARCA2 MPHOSPH10 WASHC2A ERBIN | 4.64e-06 | 472 | 92 | 9 | 38943005 | |
| Pubmed | EEF1B2 EEF1D RBM25 CEBPZ XRN1 SMARCA2 RCN2 CHD4 MPHOSPH10 CTNNA1 HNRNPUL1 SSRP1 ERBIN TOP2A | 5.01e-06 | 1247 | 92 | 14 | 27684187 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DMXL2 RBM25 SUPT6H BMS1 RCN2 ZNF638 APLP2 CHD4 HNRNPUL1 SSRP1 SEC63 PBXIP1 TOP2B | 5.47e-06 | 1082 | 92 | 13 | 38697112 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EEF1B2 OSBP EEF1D RAB3GAP1 CTR9 RCN2 LTV1 CTNNA1 HNRNPUL1 SSRP1 IPO4 WASHC2A NCAPH SNX2 PPM1G | 6.20e-06 | 1455 | 92 | 15 | 22863883 |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 6.29e-06 | 170 | 92 | 6 | 16159877 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 34000008 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24048577 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32218491 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20827171 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 18828194 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 1309226 | ||
| Pubmed | Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. | 6.92e-06 | 2 | 92 | 2 | 19222228 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2555055 | ||
| Pubmed | Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. | 6.92e-06 | 2 | 92 | 2 | 23399433 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 30169847 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 1331984 | ||
| Pubmed | Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells. | 6.92e-06 | 2 | 92 | 2 | 15044480 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17526531 | ||
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 6.92e-06 | 2 | 92 | 2 | 36717248 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 31106979 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16091284 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9155056 | ||
| Interaction | POLR1G interactions | VPS72 SLC4A1AP CEBPZ SUPT6H CTR9 CFDP1 RSF1 BMS1 KRI1 MPHOSPH10 TAF1 SNX21 SSRP1 IPO4 TOP2A TOP2B PPM1G DDX10 | 5.75e-12 | 489 | 91 | 18 | int:POLR1G |
| Interaction | PYHIN1 interactions | SUPT6H CTR9 CWC15 RSF1 RCN2 KRI1 APLP2 EGFLAM LTV1 CHD4 MPHOSPH10 SSRP1 TOP2A TOP2B PPM1G | 6.67e-11 | 358 | 91 | 15 | int:PYHIN1 |
| Interaction | CSNK2A1 interactions | EEF1B2 OSBP EEF1D STRN VPS72 CCDC82 SLC4A1AP SUPT6H CTR9 ECD CFDP1 RSF1 BMS1 CUL9 LTV1 CHD4 MPHOSPH10 CTNNA1 TAF1 SSRP1 TOP2A | 1.19e-09 | 956 | 91 | 21 | int:CSNK2A1 |
| Interaction | ZNF330 interactions | SLC4A1AP CEBPZ SUPT6H CTR9 CFDP1 RSF1 BMS1 KRI1 TAF1 SSRP1 IPO4 TOP2A TOP2B PPM1G DDX10 | 1.40e-09 | 446 | 91 | 15 | int:ZNF330 |
| Interaction | SMC5 interactions | EEF1B2 EEF1D RBM25 ZBTB33 VPS72 SLC4A1AP CEBPZ CWC15 RSF1 ZNF638 KRI1 NOL7 CHD4 MPHOSPH10 TAF1 HNRNPUL1 SSRP1 FANCM TOP2A TOP2B DDX10 | 2.66e-09 | 1000 | 91 | 21 | int:SMC5 |
| Interaction | SNRNP40 interactions | RBM25 VPS72 SLC4A1AP CEBPZ SUPT6H CWC15 ECD RSF1 ZNF316 BMS1 KRI1 CUL9 MPHOSPH10 HNRNPUL1 SSRP1 TOP2A TOP2B | 3.31e-09 | 637 | 91 | 17 | int:SNRNP40 |
| Interaction | DDX23 interactions | RBM25 CEBPZ SUPT6H CTR9 CWC15 BMS1 ZNF638 KRI1 CHD4 MPHOSPH10 TAF1 SSRP1 TOP2A TOP2B DDX10 | 3.78e-09 | 480 | 91 | 15 | int:DDX23 |
| Interaction | SIRT7 interactions | RBM25 CEBPZ SUPT6H RSF1 BMS1 XRN1 SMARCA2 ZNF638 KRI1 CUL9 CHD4 MPHOSPH10 CTNNA1 HNRNPUL1 IPO4 TOP2A PPM1G DDX10 | 4.99e-09 | 744 | 91 | 18 | int:SIRT7 |
| Interaction | CIT interactions | EEF1B2 EEF1D RBM25 VPS72 CEBPZ SUPT6H CTR9 CWC15 RSF1 BMS1 SMARCA2 RCN2 ZNF638 KRI1 NOL7 CHD4 MPHOSPH10 CTNNA1 HNRNPUL1 SSRP1 TOP2A SNX2 TOP2B DDX10 | 1.68e-08 | 1450 | 91 | 24 | int:CIT |
| Interaction | H2AB2 interactions | 2.86e-08 | 107 | 91 | 8 | int:H2AB2 | |
| Interaction | EP300 interactions | EEF1B2 OSBP EEF1D FRAS1 STRN RBM25 ZBTB33 VPS72 SUPT6H CTR9 CFDP1 RSF1 SMARCA2 RCN2 KRI1 CHD4 HNRNPUL1 SSRP1 IPO4 SEC63 TOP2A TOP2B PPM1G | 4.18e-08 | 1401 | 91 | 23 | int:EP300 |
| Interaction | NR2C2 interactions | EEF1B2 EEF1D RBM25 CEBPZ CCDC47 CTR9 CWC15 BMS1 SMARCA2 KRI1 NOL7 LTV1 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 IPO4 SEC63 NCAPH TOP2A SNX2 TOP2B DDX10 | 4.29e-08 | 1403 | 91 | 23 | int:NR2C2 |
| Interaction | RPL31 interactions | EEF1B2 CEBPZ CCDC47 SUPT6H UVSSA BMS1 KRI1 LTV1 CHD4 MPHOSPH10 TAF1 NCAPH TOP2A TOP2B PPM1G DDX10 | 5.86e-08 | 680 | 91 | 16 | int:RPL31 |
| Interaction | PARP1 interactions | RBM25 VPS72 CEBPZ SUPT6H CTR9 ECD RSF1 BMS1 SMARCA2 KRI1 CHD4 MPHOSPH10 CTNNA1 HNRNPUL1 SSRP1 IPO4 NCAPH TOP2A SNX2 TOP2B PPM1G DDX10 | 6.43e-08 | 1316 | 91 | 22 | int:PARP1 |
| Interaction | UTP4 interactions | 7.58e-08 | 170 | 91 | 9 | int:UTP4 | |
| Interaction | IFI16 interactions | RBM25 SLC4A1AP CEBPZ BMS1 XRN1 RCN2 ZNF638 KRI1 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 TOP2A TOP2B PPM1G DDX10 | 1.14e-07 | 714 | 91 | 16 | int:IFI16 |
| Interaction | CENPA interactions | CEBPZ CCDC47 RSF1 BMS1 SMARCA2 KRI1 TAF1 SSRP1 IPO4 TOP2A TOP2B PPM1G | 1.29e-07 | 377 | 91 | 12 | int:CENPA |
| Interaction | E2F4 interactions | RAB3GAP1 RBM25 MYLK CEBPZ CWC15 BMS1 PBK MPHOSPH10 CTNNA1 SSRP1 TOP2A PPM1G DDX10 CDC42EP1 | 1.34e-07 | 540 | 91 | 14 | int:E2F4 |
| Interaction | H1-4 interactions | EEF1D CEBPZ CTR9 RSF1 BMS1 XRN1 ZNF638 KRI1 LTV1 CHD4 MPHOSPH10 HNRNPUL1 NCAPH TOP2B DDX10 | 2.31e-07 | 656 | 91 | 15 | int:H1-4 |
| Interaction | H2BC8 interactions | VPS72 SLC4A1AP CCDC47 CFDP1 RSF1 BMS1 AKAP11 CHD4 SSRP1 IPO4 TOP2A TOP2B PPM1G DDX10 | 2.93e-07 | 576 | 91 | 14 | int:H2BC8 |
| Interaction | ADARB1 interactions | EEF1B2 EEF1D RBM25 ZBTB33 CEBPZ BMS1 ZNF638 CHD4 MPHOSPH10 SSRP1 TOP2A TOP2B DDX10 | 2.95e-07 | 489 | 91 | 13 | int:ADARB1 |
| Interaction | RBM4B interactions | CEBPZ XRN1 ZNF638 KRI1 LTV1 MPHOSPH10 HNRNPUL1 TOP2A SNX2 DDX10 | 2.96e-07 | 262 | 91 | 10 | int:RBM4B |
| Interaction | NAA40 interactions | EEF1B2 ZBTB33 WASHC2C CWC15 ECD CFDP1 RSF1 XRN1 ZNF638 LTV1 CHD4 HNRNPUL1 SSRP1 NCAPH ERBIN TOP2A TOP2B DDX10 | 3.14e-07 | 978 | 91 | 18 | int:NAA40 |
| Interaction | BIRC3 interactions | EEF1B2 EEF1D RBM25 CEBPZ CCDC47 SUPT6H CTR9 BMS1 RCN2 KRI1 NOL7 APLP2 CHD4 HNRNPUL1 SSRP1 IPO4 SEC63 TOP2A SNX2 TOP2B DDX10 | 3.72e-07 | 1334 | 91 | 21 | int:BIRC3 |
| Interaction | POLR1E interactions | VPS72 CEBPZ CTR9 BMS1 KRI1 MPHOSPH10 TAF1 HNRNPUL1 SSRP1 TOP2B PPM1G | 5.08e-07 | 350 | 91 | 11 | int:POLR1E |
| Interaction | RPS24 interactions | EEF1B2 CEBPZ BMS1 KRI1 LTV1 CHD4 MPHOSPH10 CTNNA1 NCAPH TOP2A TOP2B PPM1G DDX10 | 7.17e-07 | 529 | 91 | 13 | int:RPS24 |
| Interaction | H2BC9 interactions | FRAS1 VPS72 OTOF CEBPZ CFDP1 CUL9 NOL7 AKAP11 CHD4 SSRP1 CFAP44 TOP2A | 7.74e-07 | 446 | 91 | 12 | int:H2BC9 |
| Interaction | H2AZ1 interactions | VPS72 CFDP1 RSF1 AKAP11 CHD4 SSRP1 NCAPH TOP2A TOP2B MYLK2 PPM1G | 9.01e-07 | 371 | 91 | 11 | int:H2AZ1 |
| Interaction | RAD18 interactions | SLC4A1AP SUPT6H CTR9 RSF1 ZNF638 CHD4 CTNNA1 HNRNPUL1 SSRP1 ERBIN TOP2A TOP2B | 9.99e-07 | 457 | 91 | 12 | int:RAD18 |
| Interaction | COIL interactions | CEBPZ MYO10 SUPT6H CTR9 UVSSA CFDP1 BMS1 CHD4 TAF1 SSRP1 IPO4 TOP2A TOP2B | 1.15e-06 | 552 | 91 | 13 | int:COIL |
| Interaction | H2AC8 interactions | 1.38e-06 | 177 | 91 | 8 | int:H2AC8 | |
| Interaction | NOP56 interactions | CEBPZ BMS1 SMARCA2 RCN2 KRI1 CHD4 MPHOSPH10 SSRP1 TOP2A TOP2B MYLK2 PPM1G DDX10 | 1.65e-06 | 570 | 91 | 13 | int:NOP56 |
| Interaction | HECTD1 interactions | RBM25 CEBPZ BMS1 XRN1 KRI1 NOL7 LTV1 CHD4 MPHOSPH10 TAF1 HNRNPUL1 SSRP1 NCAPH ZNHIT3 TOP2A TOP2B DDX10 | 1.68e-06 | 984 | 91 | 17 | int:HECTD1 |
| Interaction | DHX40 interactions | 1.89e-06 | 249 | 91 | 9 | int:DHX40 | |
| Interaction | H3C1 interactions | CTR9 CFDP1 RSF1 SMARCA2 ZNF638 KRI1 LTV1 CHD4 TAF1 SSRP1 IPO4 TOP2A TOP2B MYLK2 PPM1G DDX10 | 2.49e-06 | 901 | 91 | 16 | int:H3C1 |
| Interaction | H2BC21 interactions | VPS72 OTOF SUPT6H CTR9 CFDP1 RSF1 ZNF638 AKAP11 CHD4 SSRP1 TOP2A TOP2B PPM1G BAHCC1 | 2.75e-06 | 696 | 91 | 14 | int:H2BC21 |
| Interaction | SUPT16H interactions | RBM25 CCDC82 SUPT6H CTR9 RSF1 SMARCA2 KRI1 CHD4 SSRP1 TOP2B PPM1G | 4.88e-06 | 442 | 91 | 11 | int:SUPT16H |
| Interaction | CEBPB interactions | EEF1B2 EEF1D RBM25 ZBTB33 CCDC47 CTR9 RSF1 BMS1 XRN1 SMARCA2 RCN2 ZNF638 NOL7 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 NCAPH TOP2A PPM1G | 5.28e-06 | 1443 | 91 | 20 | int:CEBPB |
| Interaction | DNAJC1 interactions | RAB3GAP1 CCDC47 ECD VPS13A RCN2 AKAP11 LTV1 SEC63 PBXIP1 PPM1G | 5.33e-06 | 361 | 91 | 10 | int:DNAJC1 |
| Interaction | EFTUD2 interactions | EEF1B2 EEF1D CEBPZ CCDC47 CTR9 ECD PBK SMARCA2 ZNF638 KRI1 CUL9 LTV1 CHD4 CTNNA1 HNRNPUL1 SSRP1 NCAPH TOP2A TOP2B PPM1G | 5.62e-06 | 1449 | 91 | 20 | int:EFTUD2 |
| Interaction | FBL interactions | CEBPZ ZNF316 BMS1 KRI1 NOL7 LTV1 CHD4 MPHOSPH10 SSRP1 ZNHIT3 TOP2A TOP2B DDX10 | 5.74e-06 | 639 | 91 | 13 | int:FBL |
| Interaction | ZBTB2 interactions | 5.78e-06 | 450 | 91 | 11 | int:ZBTB2 | |
| Interaction | TERF2IP interactions | VPS72 SLC4A1AP SUPT6H CWC15 CFDP1 RSF1 ZNF638 TAF1 SSRP1 TOP2A PPM1G DDX10 | 6.98e-06 | 552 | 91 | 12 | int:TERF2IP |
| Interaction | RNF2 interactions | EEF1D ZBTB33 CEBPZ RSF1 BMS1 ZNF638 NOL7 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 IPO4 NCAPH PBXIP1 TOP2A | 7.22e-06 | 866 | 91 | 15 | int:RNF2 |
| Interaction | VAPB interactions | PITPNM2 OSBP RAB3GAP1 CEBPZ CCDC47 VPS13A PITPNM3 AKAP11 SEC63 WASHC2A SNX2 | 7.72e-06 | 464 | 91 | 11 | int:VAPB |
| Interaction | RPL35 interactions | EEF1B2 CEBPZ BMS1 KRI1 LTV1 CHD4 MPHOSPH10 HNRNPUL1 NCAPH TOP2A TOP2B DDX10 | 7.78e-06 | 558 | 91 | 12 | int:RPL35 |
| Interaction | DNAJB6 interactions | 8.16e-06 | 379 | 91 | 10 | int:DNAJB6 | |
| Interaction | H3C6 interactions | 8.44e-06 | 226 | 91 | 8 | int:H3C6 | |
| Interaction | DNAJC8 interactions | 9.59e-06 | 230 | 91 | 8 | int:DNAJC8 | |
| Interaction | H2AC17 interactions | 1.02e-05 | 232 | 91 | 8 | int:H2AC17 | |
| Interaction | USP36 interactions | CEBPZ BMS1 ZNF638 KRI1 NOL7 CHD4 MPHOSPH10 SSRP1 TOP2A PRIMPOL PPM1G DDX10 | 1.58e-05 | 599 | 91 | 12 | int:USP36 |
| Interaction | TCEANC2 interactions | 1.63e-05 | 34 | 91 | 4 | int:TCEANC2 | |
| Interaction | EGLN3 interactions | DMXL2 HROB RAB3GAP1 ZBTB33 CCDC47 ECD CCSER2 XRN1 RCN2 AKAP11 LTV1 CTNNA1 IPO4 NCAPH ERBIN SNX2 PPM1G CDC42EP1 | 1.66e-05 | 1296 | 91 | 18 | int:EGLN3 |
| Interaction | CHD4 interactions | RBM25 SUPT6H CTR9 RSF1 BMS1 XRN1 SMARCA2 ZNF638 KRI1 CHD4 SSRP1 NCAPH TOP2A TOP2B DDX10 | 1.86e-05 | 938 | 91 | 15 | int:CHD4 |
| Interaction | H2BC26 interactions | 1.93e-05 | 183 | 91 | 7 | int:H2BC26 | |
| Interaction | WWTR1 interactions | 2.07e-05 | 422 | 91 | 10 | int:WWTR1 | |
| Interaction | FGFBP1 interactions | 2.14e-05 | 257 | 91 | 8 | int:FGFBP1 | |
| Interaction | RPS16 interactions | RBM25 CCDC47 BMS1 XRN1 KRI1 LTV1 CHD4 MPHOSPH10 HNRNPUL1 NCAPH TOP2A TOP2B DDX10 | 2.16e-05 | 724 | 91 | 13 | int:RPS16 |
| Interaction | NUP43 interactions | VPS72 CEBPZ SUPT6H RSF1 ZNF316 BMS1 CCSER2 KRI1 MPHOSPH10 SSRP1 TOP2A TOP2B | 2.40e-05 | 625 | 91 | 12 | int:NUP43 |
| Interaction | SIRT6 interactions | VPS72 CEBPZ SUPT6H CTR9 CCSER2 SMARCA2 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 TOP2A TOP2B | 2.52e-05 | 628 | 91 | 12 | int:SIRT6 |
| Interaction | SRRM1 interactions | 2.78e-05 | 348 | 91 | 9 | int:SRRM1 | |
| Interaction | H3-3A interactions | SLC4A1AP CFDP1 RSF1 CHD4 TAF1 SSRP1 IPO4 TOP2A SNX2 TOP2B MYLK2 PPM1G DDX10 | 3.08e-05 | 749 | 91 | 13 | int:H3-3A |
| Interaction | UHRF2 interactions | 3.42e-05 | 200 | 91 | 7 | int:UHRF2 | |
| Interaction | ZC3H10 interactions | 3.42e-05 | 200 | 91 | 7 | int:ZC3H10 | |
| Interaction | H2AB3 interactions | 3.52e-05 | 136 | 91 | 6 | int:H2AB3 | |
| Interaction | PRPF19 interactions | 3.57e-05 | 450 | 91 | 10 | int:PRPF19 | |
| Interaction | RPL11 interactions | EEF1B2 EEF1D COPS9 CEBPZ BMS1 LTV1 CHD4 MPHOSPH10 SSRP1 NCAPH TOP2A DDX10 | 3.63e-05 | 652 | 91 | 12 | int:RPL11 |
| Interaction | HOOK3 interactions | 3.64e-05 | 202 | 91 | 7 | int:HOOK3 | |
| Interaction | RPA4 interactions | EEF1B2 STRN RBM25 RIPOR2 ZNF638 SSRP1 SEC63 WASHC2A NCAPH TOP2A | 3.70e-05 | 452 | 91 | 10 | int:RPA4 |
| Interaction | BAZ1B interactions | 3.88e-05 | 204 | 91 | 7 | int:BAZ1B | |
| Interaction | SNRNP200 interactions | 4.29e-05 | 460 | 91 | 10 | int:SNRNP200 | |
| Interaction | DNAJC25 interactions | 4.36e-05 | 284 | 91 | 8 | int:DNAJC25 | |
| Interaction | H1-2 interactions | SLC4A1AP CEBPZ CTR9 RSF1 BMS1 XRN1 KRI1 APLP2 AKAP11 CHD4 MPHOSPH10 NCAPH | 4.46e-05 | 666 | 91 | 12 | int:H1-2 |
| Interaction | MEN1 interactions | EEF1D RBM25 WASHC2C CEBPZ BMS1 ZNF638 KRI1 CHD4 MPHOSPH10 TAF1 SSRP1 ERBIN TOP2A TOP2B DDX10 | 5.40e-05 | 1029 | 91 | 15 | int:MEN1 |
| Interaction | DNAJC9 interactions | 5.83e-05 | 296 | 91 | 8 | int:DNAJC9 | |
| Interaction | SNRPA interactions | EEF1B2 RBM25 SUPT6H CTR9 CWC15 ZNF638 HNRNPUL1 SSRP1 TOP2A PPM1G | 6.35e-05 | 482 | 91 | 10 | int:SNRPA |
| Interaction | CDK8 interactions | 6.62e-05 | 222 | 91 | 7 | int:CDK8 | |
| Interaction | TOP1 interactions | RBM25 SUPT6H CTR9 CWC15 CFDP1 RSF1 ZNF638 CHD4 SSRP1 TOP2A TOP2B MYLK2 | 6.81e-05 | 696 | 91 | 12 | int:TOP1 |
| Interaction | ERCC6 interactions | 7.00e-05 | 224 | 91 | 7 | int:ERCC6 | |
| Interaction | NLE1 interactions | 7.82e-05 | 228 | 91 | 7 | int:NLE1 | |
| Interaction | NPM1 interactions | EEF1B2 OSBP EEF1D CEBPZ BMS1 ZNF638 KRI1 AKAP11 CHD4 MPHOSPH10 SSRP1 NCAPH TOP2A TOP2B PPM1G DDX10 | 8.62e-05 | 1201 | 91 | 16 | int:NPM1 |
| Interaction | PHF14 interactions | 9.02e-05 | 100 | 91 | 5 | int:PHF14 | |
| Interaction | SRSF6 interactions | 9.03e-05 | 503 | 91 | 10 | int:SRSF6 | |
| Interaction | HSF1 interactions | EEF1D RBM25 SUPT6H CWC15 RCN2 CHD4 TAF1 HNRNPUL1 SSRP1 NCAPH TOP2A | 9.29e-05 | 609 | 91 | 11 | int:HSF1 |
| Interaction | KAT6A interactions | 1.01e-04 | 510 | 91 | 10 | int:KAT6A | |
| Interaction | CUL7 interactions | EEF1B2 EEF1D RBM25 SUPT6H ZNF638 CUL9 NOL7 CHD4 CTNNA1 HNRNPUL1 SSRP1 TOP2A TOP2B | 1.05e-04 | 845 | 91 | 13 | int:CUL7 |
| Interaction | SNRNP70 interactions | RAB3GAP1 RBM25 CWC15 BMS1 ZNF638 KRI1 LTV1 CHD4 MPHOSPH10 HNRNPUL1 SSRP1 TOP2A SNX2 TOP2B | 1.27e-04 | 984 | 91 | 14 | int:SNRNP70 |
| Interaction | KLF16 interactions | 1.29e-04 | 425 | 91 | 9 | int:KLF16 | |
| Interaction | FGF8 interactions | 1.30e-04 | 108 | 91 | 5 | int:FGF8 | |
| Interaction | KCNA3 interactions | RBM25 ZBTB33 CCDC47 VPS13A XRN1 DOCK10 RCN2 LTV1 CTNNA1 SEC63 ERBIN PPM1G CDC42EP1 | 1.42e-04 | 871 | 91 | 13 | int:KCNA3 |
| Interaction | RPS6 interactions | CEBPZ CFDP1 RSF1 BMS1 XRN1 KRI1 LTV1 CHD4 MPHOSPH10 NCAPH TOP2A TOP2B DDX10 | 1.47e-04 | 874 | 91 | 13 | int:RPS6 |
| Interaction | CHD3 interactions | RBM25 CEBPZ SUPT6H CTR9 SMARCA2 KRI1 CHD4 TAF1 SSRP1 TOP2A TOP2B DDX10 | 1.50e-04 | 757 | 91 | 12 | int:CHD3 |
| Interaction | CBX3 interactions | VPS72 SLC4A1AP CFDP1 RSF1 ZNF316 RCN2 CHD4 SSRP1 TOP2A TOP2B PPM1G | 1.56e-04 | 646 | 91 | 11 | int:CBX3 |
| Interaction | H2BC1 interactions | 1.56e-04 | 178 | 91 | 6 | int:H2BC1 | |
| Interaction | RPL8 interactions | EEF1B2 CEBPZ MYO10 BMS1 XRN1 CHD4 MPHOSPH10 NCAPH TOP2A DDX10 | 1.59e-04 | 539 | 91 | 10 | int:RPL8 |
| Interaction | PTGES3 interactions | 1.59e-04 | 437 | 91 | 9 | int:PTGES3 | |
| Interaction | RPL4 interactions | EEF1B2 CEBPZ BMS1 XRN1 ZNF638 KRI1 CHD4 MPHOSPH10 SEC63 NCAPH TOP2A DDX10 | 1.64e-04 | 764 | 91 | 12 | int:RPL4 |
| Interaction | H2BC10 interactions | 1.67e-04 | 61 | 91 | 4 | int:H2BC10 | |
| Interaction | NAP1L1 interactions | 1.68e-04 | 345 | 91 | 8 | int:NAP1L1 | |
| Interaction | H2BC6 interactions | 1.78e-04 | 62 | 91 | 4 | int:H2BC6 | |
| GeneFamily | Topoisomerases | 1.35e-04 | 6 | 55 | 2 | 1050 | |
| GeneFamily | WASH complex | 1.35e-04 | 6 | 55 | 2 | 1331 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 1.35e-04 | 6 | 55 | 2 | 1151 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.50e-03 | 29 | 55 | 2 | 396 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 3.50e-03 | 29 | 55 | 2 | 754 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.55e-03 | 206 | 55 | 4 | 682 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SLC4A1AP CEBPZ MYO10 CCDC47 RSF1 PBK SMARCA2 DOCK10 RCN2 ZNF638 AKAP11 MPHOSPH10 SEC63 SNX2 TOP2B DDX10 | 1.07e-09 | 656 | 92 | 16 | M18979 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 7.79e-07 | 90 | 92 | 6 | M39250 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 RAB3GAP1 MYO10 DOCK9 CCSER2 VPS13A SMARCA2 ZNF638 AKAP11 SPIDR WASF1 TOP2A SNX2 DDX10 | 1.68e-06 | 856 | 92 | 14 | M4500 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | EEF1B2 STRN RIPOR2 ZBTB33 CEBPZ CTR9 ECD BMS1 DOCK10 RCN2 CUL9 TAF1 ZNHIT3 TOP2A SNX2 TOP2B DDX10 | 6.28e-06 | 1394 | 92 | 17 | M9585 |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP | 6.64e-06 | 199 | 92 | 7 | M7821 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN | 6.64e-06 | 199 | 92 | 7 | M7824 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | OSBP EEF1D RAB3GAP1 RBM25 SLC4A1AP CEBPZ CCDC47 SUPT6H CFDP1 NOL7 LTV1 MPHOSPH10 HNRNPUL1 SSRP1 YIPF3 | 8.67e-06 | 1129 | 92 | 15 | M42508 |
| Coexpression | SCIBETTA_KDM5B_TARGETS_DN | 8.76e-06 | 79 | 92 | 5 | M6787 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | OSBP EEF1D RAB3GAP1 RBM25 SLC4A1AP CEBPZ CCDC47 SUPT6H CFDP1 NOL7 LTV1 MPHOSPH10 HNRNPUL1 SSRP1 YIPF3 | 1.17e-05 | 1158 | 92 | 15 | MM1338 |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 4.35e-05 | 181 | 92 | 6 | M2641 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 4.94e-05 | 481 | 92 | 9 | M3898 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 5.79e-05 | 612 | 92 | 10 | M4772 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 6.96e-05 | 197 | 92 | 6 | M8983 | |
| Coexpression | FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP | 7.04e-05 | 23 | 92 | 3 | M8108 | |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 7.36e-05 | 199 | 92 | 6 | M7099 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_DC_UP | 7.36e-05 | 199 | 92 | 6 | M4475 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN | 7.57e-05 | 200 | 92 | 6 | M3628 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 7.57e-05 | 200 | 92 | 6 | M8851 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | 1.06e-04 | 307 | 92 | 7 | M39058 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-10 | 184 | 92 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-09 | 185 | 92 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.96e-09 | 197 | 92 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.72e-06 | 175 | 92 | 6 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 176 | 92 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 2.09e-06 | 181 | 92 | 6 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 182 | 92 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 191 | 92 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 191 | 92 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 191 | 92 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.94e-06 | 192 | 92 | 6 | b86476037ddf8904c1d8a6b3763af7242c031cf3 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.94e-06 | 192 | 92 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.03e-06 | 193 | 92 | 6 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.12e-06 | 194 | 92 | 6 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 3.31e-06 | 196 | 92 | 6 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 3.31e-06 | 196 | 92 | 6 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 3.31e-06 | 196 | 92 | 6 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.40e-06 | 197 | 92 | 6 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-06 | 199 | 92 | 6 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-dn_T|IIF / Disease, condition lineage and cell class | 3.71e-06 | 200 | 92 | 6 | c34fff02992cba6bcc2308019cb00b94e1227300 | |
| ToppCell | IIF-Lymphocyte-T_NK-dnT|IIF / Disease, Lineage and Cell Type | 1.32e-05 | 146 | 92 | 5 | d0f361662db5f7be26104346e8431f7e30c5ce3a | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.99e-05 | 159 | 92 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.51e-05 | 167 | 92 | 5 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 182 | 92 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 182 | 92 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 3.89e-05 | 183 | 92 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.89e-05 | 183 | 92 | 5 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-05 | 184 | 92 | 5 | 7f8488dbb1ee41372cdbcd34a2e14b377218bf0f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.21e-05 | 186 | 92 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 190 | 92 | 5 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 190 | 92 | 5 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.77e-05 | 191 | 92 | 5 | c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8 | |
| ToppCell | (1)_Control_(PBS)|World / Stress and Cell class | 4.77e-05 | 191 | 92 | 5 | b346e13259cb2d506b923ad44b894c21a3eee4c3 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.77e-05 | 191 | 92 | 5 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-05 | 193 | 92 | 5 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.01e-05 | 193 | 92 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-05 | 193 | 92 | 5 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-05 | 193 | 92 | 5 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.14e-05 | 194 | 92 | 5 | 6115c20ffe414378508f3879e67815b6062341a7 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.14e-05 | 194 | 92 | 5 | 6317e9cdf96eb020f84d50bf41f803db5c9c04a0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | PND28-Endothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.14e-05 | 194 | 92 | 5 | b592c713204db7ae2f34a54f2d03d13834593c57 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 5.26e-05 | 195 | 92 | 5 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.26e-05 | 195 | 92 | 5 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 195 | 92 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 5.39e-05 | 196 | 92 | 5 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | B_cell_maturation-CD34+_pro-B|World / Lineage and Cell class | 5.39e-05 | 196 | 92 | 5 | 4cb046883e56524963f6469ddb3b82c3c9853379 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.52e-05 | 197 | 92 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 5.52e-05 | 197 | 92 | 5 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 5.66e-05 | 198 | 92 | 5 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.66e-05 | 198 | 92 | 5 | 50f236ab7ef6f00721f6cd714e3eee183077beeb | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.66e-05 | 198 | 92 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.66e-05 | 198 | 92 | 5 | dc0c6189ff9dd76675f63acf1cbc7dda60e75f3f | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.79e-05 | 199 | 92 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 5.93e-05 | 200 | 92 | 5 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 200 | 92 | 5 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.93e-05 | 200 | 92 | 5 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 5.93e-05 | 200 | 92 | 5 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 5.93e-05 | 200 | 92 | 5 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.93e-05 | 200 | 92 | 5 | 243c7f88befd402a57e9226706811c802b28e3fd | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.53e-04 | 130 | 92 | 4 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-04 | 134 | 92 | 4 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 139 | 92 | 4 | 27dd36f5ef03fa97f0fdb19fbd259cb60e7962b3 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 139 | 92 | 4 | 2a54627947f8c6597c041f4785f8a4e52d0edfba | |
| ToppCell | Severe-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.03e-04 | 140 | 92 | 4 | 683ee5e103f0c68cbbec019249404d381dbc39f3 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.20e-04 | 143 | 92 | 4 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.26e-04 | 144 | 92 | 4 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.51e-04 | 148 | 92 | 4 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-04 | 150 | 92 | 4 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-04 | 150 | 92 | 4 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 154 | 92 | 4 | 8dc8f02534c3ebda30bf9e702e36d0c53d89e5a5 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.99e-04 | 155 | 92 | 4 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.29e-04 | 159 | 92 | 4 | 0fbfdb18b7ed4bde077add13f2b3636e144b254f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.37e-04 | 160 | 92 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 3.54e-04 | 162 | 92 | 4 | e088e66aabc307dde5d2b9aa295c34ef68155b1a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 163 | 92 | 4 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-04 | 163 | 92 | 4 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-04 | 164 | 92 | 4 | fb18b863152fb3109e2224c791c84c6371680a4e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-04 | 165 | 92 | 4 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 3.79e-04 | 165 | 92 | 4 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.88e-04 | 166 | 92 | 4 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 3.88e-04 | 166 | 92 | 4 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 3.88e-04 | 166 | 92 | 4 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.88e-04 | 166 | 92 | 4 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.97e-04 | 167 | 92 | 4 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 167 | 92 | 4 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 168 | 92 | 4 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.06e-04 | 168 | 92 | 4 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 168 | 92 | 4 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 168 | 92 | 4 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 4.06e-04 | 168 | 92 | 4 | d50078614f7af74dc2aa4081c1708a5156ac51cf | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 168 | 92 | 4 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 169 | 92 | 4 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 169 | 92 | 4 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-04 | 170 | 92 | 4 | 21bfe070e63722672176052b386167ea4c3dc4e5 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-04 | 171 | 92 | 4 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.34e-04 | 171 | 92 | 4 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | Control-PLT_5|Control / Disease Group and Platelet Clusters | 4.43e-04 | 172 | 92 | 4 | 950d0a5b7908ee6ef8d30f123c9c7f7180dd4c26 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-04 | 172 | 92 | 4 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| Drug | psi-tectorigenin | 1.03e-05 | 11 | 92 | 3 | CID005353911 | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.49e-05 | 196 | 92 | 7 | 2288_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HG-U133A | 1.54e-05 | 197 | 92 | 7 | 1948_UP | |
| Drug | AC1LD6BO | 1.62e-05 | 2 | 92 | 2 | CID000612818 | |
| Drug | Dexrazoxane | 1.62e-05 | 2 | 92 | 2 | DB00380 | |
| Drug | 5-undecyloxolan-2-one | 1.62e-05 | 2 | 92 | 2 | CID000007785 | |
| Drug | F14512 | 1.62e-05 | 2 | 92 | 2 | ctd:C534191 | |
| Drug | Daunorubicin | 1.62e-05 | 2 | 92 | 2 | DB00694 | |
| Drug | Vitamin K 3 | RAB3GAP1 MYLK MYO10 CTR9 BMS1 FAM174B KRI1 NOL7 APLP2 LTV1 SNX21 SEC63 NCAPH ERBIN TOP2A TOP2B | 3.72e-05 | 1249 | 92 | 16 | ctd:D024483 |
| Drug | Ps 9 | 4.83e-05 | 3 | 92 | 2 | CID000066348 | |
| Drug | MS-444 | 4.83e-05 | 3 | 92 | 2 | CID000132904 | |
| Disease | B cell deficiency (implicated_via_orthology) | 9.00e-06 | 2 | 89 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 5.82e-04 | 12 | 89 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | QRS duration, response to sulfonylurea | 2.18e-03 | 23 | 89 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.18e-03 | 23 | 89 | 2 | C0018784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HDDVFEESEELSSDE | 591 | Q96RT1 | |
| LLESFAVEEDFEFDD | 1856 | Q9P281 | |
| FEFDDNSSFSEEEED | 1866 | Q9P281 | |
| DEDLDSVVVEFDDGD | 2006 | Q9P281 | |
| EFDDSDDEEDTSAAL | 36 | Q9HCE6 | |
| DEGFEDDLDLDISFE | 261 | Q63HQ2 | |
| ADFFNDFEDLFDDDD | 41 | Q8WXC6 | |
| TDQDDDEDLVDTCAF | 116 | Q8IX05 | |
| LNEEDDEDEDSTVFD | 141 | Q3ZCQ3 | |
| EDSDSEVSEFFDSFD | 346 | Q9UKA4 | |
| ANEDFDFDTEEKATE | 281 | Q6NSI1 | |
| DSDESIHSDEEDDAF | 2476 | Q8TDJ6 | |
| DFEEESDDDDTAALL | 116 | Q9P013 | |
| FADSDDDLERSSAEE | 501 | Q14692 | |
| LESDEDESESEDEVF | 1521 | Q96MT7 | |
| DESESEDEVFDDSIC | 1526 | Q96MT7 | |
| EDFECLDSDDDLDFE | 511 | O95905 | |
| DDEDDDIDLFGSDNE | 151 | P29692 | |
| IDFDENTALDDAEEE | 131 | Q14257 | |
| VDSVFNKFEDEDSDD | 691 | P49756 | |
| SEEEFFECLSDTEEL | 581 | Q15042 | |
| LEDFTEAAVDEDDED | 246 | Q06481 | |
| KDDDFEEESFDIPDN | 326 | Q9UBM8 | |
| ATWDFDDEAFDEISD | 1676 | Q15746 | |
| DDEAFDEISDDAKDF | 1681 | Q15746 | |
| EEEEFEIALADASDN | 2761 | Q86XX4 | |
| DIVAALDDDFDFDDP | 141 | Q96GA3 | |
| TDSDDDDDDVIFCSE | 186 | Q86T24 | |
| EETEFAEADQDFSDE | 566 | O43861 | |
| FLDDEAELSEEDAEY | 1511 | Q8IYD8 | |
| SVSEAKFDDFEDEED | 16 | Q96A33 | |
| FDEETFEAVSDEAKD | 501 | Q9H1R3 | |
| FQFELTLEEAEEEDE | 656 | Q08493 | |
| EDSEEDFDSRFDTDD | 1146 | Q9HD67 | |
| EEDIDFFEDIDSDED | 231 | O00566 | |
| KESFRAFVEDSEDED | 161 | Q8N9T8 | |
| VEEEFEDEDFLSAVE | 11 | Q8N3J3 | |
| DSDESSDDEFFDAHE | 336 | Q9BZ72 | |
| SDDEFFDAHEDLSDT | 341 | Q9BZ72 | |
| SDEDDENEFFDAPEI | 351 | P22059 | |
| EEEEEDEAAAAAAAA | 1356 | Q9GZU2 | |
| DDEFDDEAPEELTFA | 56 | Q9UMY1 | |
| SEDFSDDFIDIEDSN | 411 | Q9H7U1 | |
| EREDTDSFEDLEADE | 476 | A2A2Y4 | |
| DEELDSEEFDSDEEL | 41 | Q8N4S0 | |
| SEEFDSDEELDSDES | 46 | Q8N4S0 | |
| SDEELDSDESFENDE | 51 | Q8N4S0 | |
| MEEFDSEDFSTSEED | 1 | Q9UEE9 | |
| EEKDETDEFFEECIT | 356 | Q4G0P3 | |
| SFEIDHEDADKDEDT | 151 | Q96BY6 | |
| FTDSETDVEGFFEDE | 1796 | Q9BZ29 | |
| EELDDSDFETEDFDV | 636 | P35221 | |
| NTFEFADAEEDDEVK | 376 | Q00587 | |
| EFDEFVNDDTDDDLP | 916 | Q6PD62 | |
| ETFFFGDEEEDEDEA | 2501 | Q8IWT3 | |
| TQFLDRDEEEEDADF | 621 | Q13206 | |
| IDLFGSDDEEESEEA | 101 | P24534 | |
| EDDDLDVESDFDDAS | 311 | Q14839 | |
| DSESDFSDDFSDDFV | 1186 | Q96T23 | |
| SFLLFDDESDGEEEE | 631 | Q8TEX9 | |
| DEEFEELIDTFEDDN | 841 | Q03701 | |
| FLFKEEEEFTTDEAD | 471 | Q96LW4 | |
| TDEVVLEDDDFFTGE | 1741 | Q9HC10 | |
| EDEDDFDDTLVAIDT | 201 | Q9BUJ2 | |
| TDFEDLEDGEDLFTS | 16 | O60749 | |
| FLESAAADFSDEDED | 236 | O43815 | |
| SDEDEDSDLEEFVRS | 281 | Q2YD98 | |
| VVSDFDSDEEQDERE | 1566 | P51531 | |
| TFDFSEEEDDDADDD | 1371 | Q02880 | |
| EEFEDSLATDDFLVD | 16 | Q8NE09 | |
| EDEEDSEDFHSIAGD | 1851 | P21675 | |
| FFEDSEDESDEAEEE | 256 | O15355 | |
| FLNTSDFDEEEDGDE | 666 | Q9Y4F9 | |
| EEEEDVAEEFDSNAS | 486 | Q08945 | |
| QAADSDDEDLDDLFV | 566 | Q15003 | |
| ESFAFVDEDEDEDLS | 706 | P35523 | |
| SFDDRLEDDDFDLIE | 91 | Q7KZ85 | |
| DEESDIDDFIVDDDG | 176 | Q7KZ85 | |
| LPSVSEDDSEEEFFD | 831 | Q96RL7 | |
| GDDDEVDDFEDFIFS | 676 | Q96AQ6 | |
| DSDRAEASDCDEFED | 131 | Q14159 | |
| FYEDSDSEDEIEDLT | 111 | Q5TAB7 | |
| LSFTSAEDDEDDEDE | 61 | Q969T3 | |
| LEDETEDDDLFETEF | 416 | Q8IZH2 | |
| FDFDETIVDENSDDS | 31 | Q8TCT1 | |
| DSEGFEDSFEEEEEE | 741 | Q9UGP8 | |
| GLFDDEDEESDLFTE | 366 | Q9Y4E1 | |
| SLRDFVDDDDDDDLE | 41 | Q9H9C1 | |
| DEDKTFDESDFDDEA | 256 | Q96KB5 | |
| DSVESSDDEFFDARE | 26 | Q9BZ71 | |
| DSDEDFSDFDEKTDD | 1331 | P11388 | |
| FSDFDEKTDDEDFVP | 1336 | P11388 | |
| GLFDDEDEESDLFTE | 366 | Q641Q2 | |
| EVDADAADAAAAEEE | 61 | Q9GZM5 | |
| DHEEEDDEDFLAEVA | 246 | A6NFI3 | |
| VEYSDSEDDSEFDEV | 541 | Q92558 | |
| SDTEDEVDSDFDIDE | 51 | Q15906 | |
| DDSIADFLNSDEEED | 71 | Q15649 | |
| LDEVTEEDEDSLADF | 1751 | Q14966 | |
| FSSAARDDEVSEDEE | 161 | Q2T9J0 | |
| EDFYDSDDDTFLDRT | 461 | Q9BWU0 |